166 related articles for article (PubMed ID: 15308383)
1. Insulin therapy in type 2 diabetes.
Davis T; Edelman SV
Med Clin North Am; 2004 Jul; 88(4):865-95, x. PubMed ID: 15308383
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents: 2004.
Lebovitz HE
Med Clin North Am; 2004 Jul; 88(4):847-63, ix-x. PubMed ID: 15308382
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemia in type 2 diabetes.
Banarer S; Cryer PE
Med Clin North Am; 2004 Jul; 88(4):1107-16, xii-xiii. PubMed ID: 15308392
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes: the role of insulin.
Brunton S; Carmichael B; Funnell M; Lorber D; Rakel R; Rubin R
J Fam Pract; 2005 May; 54(5):445-52. PubMed ID: 15865903
[No Abstract] [Full Text] [Related]
5. In-hospital management of type 2 diabetes mellitus.
Lien LF; Angelyn Bethel M; Feinglos MN
Med Clin North Am; 2004 Jul; 88(4):1085-105, xii. PubMed ID: 15308391
[TBL] [Abstract][Full Text] [Related]
6. Current perspective in insulin therapy in the management of diabetes mellitus.
Garg MK
J Indian Med Assoc; 2002 Mar; 100(3):194-5, 202. PubMed ID: 12408284
[TBL] [Abstract][Full Text] [Related]
7. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
[TBL] [Abstract][Full Text] [Related]
8. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.
Langer O; Yogev Y; Xenakis EM; Rosenn B
Am J Obstet Gynecol; 2005 Jan; 192(1):134-9. PubMed ID: 15672015
[TBL] [Abstract][Full Text] [Related]
9. Insulin therapy for management of type 2 diabetes mellitus: strategies for initiation and long-term patient adherence.
Barag SH
J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):S13-9. PubMed ID: 21813731
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the Glitazones and the Endothelium (GATE) study: evaluation of rosiglitazone on endothelial function in patients with diabetes.
Hubacek J; Verma S; Shewchuk L; Ross SJ; Edwards A; Anderson TJ
Can J Cardiol; 2004 Dec; 20(14):1449-53. PubMed ID: 15614340
[TBL] [Abstract][Full Text] [Related]
12. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
13. Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review.
Dailey G
Curr Med Res Opin; 2004 Dec; 20(12):2007-14. PubMed ID: 15701217
[TBL] [Abstract][Full Text] [Related]
14. Optimal initiation of insulin in type 2 diabetes.
Hirsch IB; Vega CP
MedGenMed; 2005 Nov; 7(4):49. PubMed ID: 16614671
[TBL] [Abstract][Full Text] [Related]
15. Dyslipidemia in type 2 diabetes.
Krauss RM; Siri PW
Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384
[TBL] [Abstract][Full Text] [Related]
16. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
17. [Oral drugs for diabetes--update of current use and availability].
Niskanen L
Duodecim; 2004; 120(8):983-90. PubMed ID: 15185512
[No Abstract] [Full Text] [Related]
18. New-onset diabetes after liver transplantation: from pathogenesis to management.
Marchetti P
Liver Transpl; 2005 Jun; 11(6):612-20. PubMed ID: 15915488
[TBL] [Abstract][Full Text] [Related]
19. [Effect of short-term intensive insulin therapy on daily insulin requirement in poorly controlled type 2 diabetes patients].
Mozdzan M; Mozdzan M; Loba J; Markuszewski L; Ruxer J
Wiad Lek; 2006; 59(3-4):203-7. PubMed ID: 16813265
[TBL] [Abstract][Full Text] [Related]
20. [Long-acting insulin analog, glargine, in the treatment of type 1 diabetes].
Tuomi T
Duodecim; 2004; 120(1):88-92. PubMed ID: 14976814
[No Abstract] [Full Text] [Related]
[Next] [New Search]
